Avanos Medical (NYSE:AVNS) and WILLIAM DEMANT/ADR (OTCMKTS:WILYY) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends and institutional ownership.

Insider and Institutional Ownership

84.9% of Avanos Medical shares are held by institutional investors. 1.4% of Avanos Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.


This table compares Avanos Medical and WILLIAM DEMANT/ADR’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Avanos Medical 11.85% 7.61% 4.44%

Earnings & Valuation

This table compares Avanos Medical and WILLIAM DEMANT/ADR’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Avanos Medical $611.60 million 5.31 $79.30 million $2.35 29.21
WILLIAM DEMANT/ADR $2.00 billion 5.30 $266.43 million $0.52 38.38

WILLIAM DEMANT/ADR has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than WILLIAM DEMANT/ADR, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Avanos Medical has a beta of 1.76, indicating that its share price is 76% more volatile than the S&P 500. Comparatively, WILLIAM DEMANT/ADR has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Avanos Medical and WILLIAM DEMANT/ADR, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avanos Medical 1 0 2 0 2.33

Avanos Medical presently has a consensus target price of $67.50, indicating a potential downside of 1.68%. Given Avanos Medical’s higher possible upside, analysts clearly believe Avanos Medical is more favorable than WILLIAM DEMANT/ADR.


Avanos Medical beats WILLIAM DEMANT/ADR on 10 of the 13 factors compared between the two stocks.

About Avanos Medical

Avanos Medical, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. Its products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. This segment sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and other brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.


William Demant Holding A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment designed to aid the people with hearing loss connect and communication primarily in Denmark, rest of Europe, North America, Oceania, Asia, and other countries. Its products include hearing devices and implants; diagnostic instruments; and personal communication systems, such as headsets and solutions for the professional call center and office market, as well as consumer headsets for the gaming and mobile segments. The company was founded in 1904 and is headquartered in Smørum, Denmark.

Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.